Suppression of experimental autoimmune uveitis by angiotensin II type 1 receptor blocker telmisartan.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Investigative Ophthalmology and Visual Science

• Publication date

  2009-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1167/iovs.08-2649PMID 19136706
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Anti-inflammatory effect of angiotensin type 1 receptor antagonist on endotoxin-induced uveitis in rats

  2008influential reference
• Epidemiological Survey of Intraocular Inflammation in Japan

  2007cited by this paper
• Infliximab Treatment for Ocular and Extraocular Manifestations of Behçet's Disease

  2007cited by this paper
• Proteomic surveillance of autoimmunity in Behcet's disease with uveitis : selenium binding protein is a novel autoantigen in Behcet's disease

  2007cited by this paper
• Proteomic surveillance of autoimmunity in Behcet's disease with uveitis: selenium binding protein is a novel autoantigen in Behcet's disease.

  2007cited by this paper
• Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway.

  2007cited by this paper
• Human T and natural killer cells possess a functional renin-angiotensin system: further mechanisms of angiotensin II-induced inflammation.

  2007cited by this paper
• Current concepts in the etiology and treatment of Behçet disease.

  2006cited by this paper
• Angiotensin II Type 1 Receptor–Mediated Inflammation Is Required for Choroidal Neovascularization

  2006cited by this paper
• The role of the ICOS/B7RP‐1 T cell costimulatory pathway in murine experimental autoimmune uveoretinitis

  2006cited by this paper
• Common angiotensin receptor blockers may directly modulate the immune system via VDR, PPAR and CCR2b

  2006cited by this paper
• Telmisartan inhibits AGE-induced C-reactive protein production through downregulation of the receptor for AGE via peroxisome proliferator-activated receptor-gamma activation

  2006cited by this paper
• The non-thiol angiotensin-converting enzyme inhibitor quinapril suppresses inflammatory arthritis.

  2005cited by this paper
• Immunomodulatory Therapy for Ocular Inflammatory Disease: A Basic Manual and Review of the Literature

  2005cited by this paper
• Telmisartan has the strongest binding affinity to angiotensin II type 1 receptor: comparison with other angiotensin II type 1 receptor blockers.

  2005cited by this paper
• J Soc Gynecol Investig

  2005cited by this paper
• Current concepts in the etiology and treatment of Behçet disease.

  2005cited by this paper
• Suppression of ocular inflammation in endotoxin-induced uveitis by blocking the angiotensin II type 1 receptor.

  2005influential reference
• Selective suppression of pathologic, but not physiologic, retinal neovascularization by blocking the angiotensin II type 1 receptor.

  2005cited by this paper
• Angiotensin receptor blockers suppress antigen-specific T cell responses and ameliorate collagen-induced arthritis in mice.

  2005cited by this paper
• The renin-angiotensin system and the developing retinal vasculature.

  2005cited by this paper
• Antidiabetic mechanisms of angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists: beyond the renin–angiotensin system

  2004cited by this paper
• Immune mechanisms in uveitis

  2004cited by this paper
• Angiotensin II influences ovarian follicle development in the transgenic (mRen-2)27 and Sprague-Dawley rat.

  2004cited by this paper
• Angiotensin II Induces Neutrophil Accumulation In Vivo Through Generation and Release of CXC Chemokines

  2004cited by this paper
• Innate immunity in the retina: Toll-like receptor (TLR) signaling in human retinal pigment epithelial cells

  2004cited by this paper
• Immunohistochemical Localization of Angiotensin-Converting Enzyme, Angiotensin II and AT1 Receptor in Human Ocular Tissues

  2004cited by this paper
• Peritoneal Exudate Cells Treated with Calcitonin Gene-Related Peptide Suppress Murine Experimental Autoimmune Uveoretinitis via IL-101

  2004cited by this paper
• Control of dendritic cell differentiation by angiotensin II

  2003cited by this paper
• Leukocyte trafficking in experimental autoimmune uveitis: breakdown of blood-retinal barrier and upregulation of cellular adhesion molecules.

  2003cited by this paper
• Inflammation and angiotensin II.

  2003cited by this paper
• International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels

  2003cited by this paper
• Chemokine and chemokine receptor expression during experimental autoimmune uveoretinitis in mice

  2003cited by this paper
• Characterisation of a thymic renin-angiotensin system in the transgenic m(Ren-2)27 rat.

  2002cited by this paper
• Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with diabetic macular edema and other retinal disorders.

  2002cited by this paper
• Leukocyte-mediated endothelial cell injury and death in the diabetic retina.

  2001cited by this paper
• Human S-antigen determinant recognition in uveitis.

  2001cited by this paper
• Expression of the chemokines MIP-1alpha, MCP-1, and RANTES in experimental autoimmune uveitis.

  2001cited by this paper
• Humoral immune response directed against LEDGF in patients with VKH.

  2001cited by this paper
• Retinal Neovascularization Is Prevented by Blockade of the Renin-Angiotensin System

  2000cited by this paper
• International union of pharmacology. XXIII. The angiotensin II receptors.

  2000cited by this paper
• Angiotensin II stimulates intercellular adhesion molecule-1 (ICAM-1) expression by human vascular endothelial cells and increases soluble ICAM-1 release in vivo.

  1999cited by this paper
• Basic pathogenic mechanisms operating in experimental models of acute anterior uveitis

  1998cited by this paper
• Evidence that macrophages in atherosclerotic lesions contain angiotensin II.

  1998cited by this paper
• Oral tolerance in a murine model of relapsing experimental autoimmune uveoretinitis (EAU): induction of protective tolerance in primed animals

  1997cited by this paper
• The adrenal renin-angiotensin system: a local hormonal regulator of aldosterone production.

  1996cited by this paper
• Demonstration of renin mRNA, angiotensinogen mRNA, and angiotensin converting enzyme mRNA expression in the human eye: evidence for an intraocular renin-angiotensin system.

  1996cited by this paper
• Evidence that angiotensin II is present in human monocytes.

  1995cited by this paper
• Immunol. Cell Biol.

  1995cited by this paper
• Suppression of experimental uveitis with monoclonal antibodies to ICAM-1 and LFA-1.

  1994influential reference
• The Basis and Evidence of a Role for the Ovarian Renin-Angiotensin System in Health and Disease

  1994cited by this paper
• Pathology of experimental autoimmune uveoretinitis in mice.

  1990cited by this paper

• NETs‐CD44‐IL‐17A Feedback Loop Drives Th17‐Mediated Inflammation in Behçet's Uveitis

  2025cites this paper
• Revisiting the renin-angiotensin-aldosterone system in the eye: mechanistic insights and pharmacological targets.

  2025cites this paper
• Dynamics of Inflammatory Factors in Aqueous Humor During Brolucizumab Treatment for Age-Related Macular Degenerations: A Case Series

  2025cites this paper
• Upregulation, Functional Association, and Correlated Expressions of TRPV1 and TRPA1 During Telmisartan-Driven Immunosuppression of T Cells

  2024cites this paper
• Therapeutic effects of candesartan in inflammatory skin disorders by suppressing Th17 differentiation.

  2023cites this paper
• Granulomatous manifestations associated with COVID19 infection: Is there a link between these two diseases?

  2021cites this paper
• Adenosine: The common target between cancer immunotherapy and glaucoma in the eye.

  2021cites this paper
• Angiotensin II Induces Oxidative Stress and Endothelial Dysfunction in Mouse Ophthalmic Arteries via Involvement of AT1 Receptors and NOX2

  2021cites this paper
• Involvement of dopaminergic signaling in the cross talk between the renin-angiotensin system and inflammation

  2020cites this paper
• Local ocular renin–angiotensin–aldosterone system: any connection with intraocular pressure? A comprehensive review

  2020cites this paper
• Angiotensin‐converting enzyme as a new immunologic target for the new SARS‐CoV‐2

  2020cites this paper
• Receptor-Associated Prorenin System in the Trabecular Meshwork of Patients with Primary Open-Angle Glaucoma and Neovascular Glaucoma

  2020cites this paper
• Retinal microglia initiate neuroinflammation in ocular autoimmunity

  2019cites this paper
• A Novel Single-Strand RNAi Therapeutic Agent Targeting the (Pro)renin Receptor Suppresses Ocular Inflammation

  2017cites this paper
• Renin-angiotensin system gene polymorphisms as risk factors for multiple sclerosis.

  2016cites this paper
• The lack of association between angiotensin‐converting enzyme gene insertion/deletion polymorphism and nicotine dependence in multiple sclerosis

  2016cites this paper
• Therapeutic targets of renin-angiotensin system in ocular disorders

  2016cites this paper
• Smoking worsens multiple sclerosis prognosis: two different pathways are involved.

  2015cites this paper
• The ocular endothelin system: a novel target for the treatment of endotoxin-induced uveitis with bosentan.

  2014cites this paper
• Effects of Inhibitors of the Renin-Angiotensin System on the Efficacy of Interferon beta-1b: A post hoc Analysis of the BEYOND Study

  2014cites this paper
• The ocular renin-angiotensin system: a therapeutic target for the treatment of ocular disease.

  2014cites this paper
• Peroxisome proliferator-activated receptor-γ agonist pioglitazone suppresses experimental autoimmune uveitis.

  2013cites this paper
• A Modern Understanding of the Traditional and Nontraditional Biological Functions of Angiotensin-Converting Enzyme

  2013cites this paper
• Telmisartan Plus Propranolol Improves Liver Fibrosis and Bile Duct Proliferation in the PSC-Like Abcb4−/− Mouse Model

  2013cites this paper
• TELMISARATAN PROVIDES BETTER RENAL PROTECTION THAN VALSARTAN IN A RAT MODEL OF METABOLIC SYNDROME

  2013cites this paper
• Mind over cytokines: Crosstalk and regulation between the neuroendocrine and immune systems

  2012cites this paper
• Renin-Angiotensin System Hyperactivation Can Induce Inflammation and Retinal Neural Dysfunction

  2012cites this paper
• Telmisartan provides better renal protection than valsartan in a rat model of metabolic syndrome.

  2011cites this paper
• Local renin-angiotensin II systems, angiotensin-converting enzyme and its homologue ACE2: their potential role in the pathogenesis of chronic obstructive pulmonary diseases, pulmonary hypertension and acute respiratory distress syndrome.

  2011cites this paper
• Emerging role of antioxidants in the protection of uveitis complications.

  2011cites this paper
• LOX-1 and Angiotensin Receptors, and Their Interplay

  2011cites this paper
• Complexation and Mechanism of Fluorescence Quenching of Telmisartan with Y(III) and Nd(III)

  2010cites this paper
• Angiotensin II sustains brain inflammation in mice via TGF-beta.

  2010cites this paper
• Angiotensin II revisited: new roles in inflammation, immunology and aging

  2010cites this paper
• Role of the renin-angiotensin system in autoimmune inflammation of the central nervous system

  2009cites this paper